Welltower Inc.
NYSE:WELLREIT - Healthcare Facilities
+$0.44 today
- Market cap
- $181.39B
- Beta
- 0.78
- P/E (TTM)
- 102.9
- EPS (TTM)
- $2.01
- Dividend yield
- 1.43%
Volume 4.27M
Average 3.24M
WELL Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Welltower Inc.NYSE: WELL
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue remains negative
Q3 FY2026 cost of revenue was $0, compared with $1.58B a year earlier. Trailing-twelve-month cost of revenue was $6.14B. Over 3 fiscal years it compounded at +22.2% a year.
Context
- Cost of revenue amounted to 60.8% of revenue in FY2025, down 0.7 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly cost of revenue holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.53B.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 6.49B USD
- Year-over-year change
- +34.3%
- 4-year CAGR
- +23.7%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.49B | +34.3% |
| FY2024 | 2024-12-31 | 4.83B | +22.4% |
| FY2023 | 2023-12-31 | 3.95B | +10.9% |
| FY2022 | 2022-12-31 | 3.56B | +28.3% |
| FY2021 | 2021-12-31 | 2.77B | — |
Cost of Revenue vs competitors
How WELL compares with its peers on the latest reported figures
- WELL's LTM Sep 2026 cost of revenue of $6.14B is the 2nd highest of the 11 companies compared; the peer median is $276.99M.
- Its year-over-year change of +3.0% is the 9th highest of 11, against a peer median of +123.2%.
- Cost of revenue amounts to 44.8% of revenue for WELL, versus a peer median of 43.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.61B | +115.3% | +39.4% | 102.6% | |
| LTM Sep 2026 | $6.14B | +3.0% | +22.2% | 44.8% | |
| LTM Sep 2026 | $2.58B | +131.0% | +36.4% | 115.1% | |
| LTM Sep 2026 | $2.25B | +29.1% | +11.9% | 84.3% | |
| LTM Jun 2026 | $362.27M | +2568.6% | +250.1% | 28.0% | |
| LTM Jun 2026 | $327.99M | +37.0% | +18.6% | 38.2% | |
| LTM Sep 2026 | $225.99M | +1907.9% | +190.4% | 49.4% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $213.63M | -4.4% | +0.8% | 62.4% |
| LTM Sep 2026 | $139.08M | +262.4% | +61.6% | 35.3% | |
| LTM Sep 2026 | $136.24M | +1127.6% | +174.9% | 22.1% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $28.46M | -12.9% | -7.3% | 2.8% |
| Peer median (excluding WELL) | $276.99M | +123.2% | +37.9% | 43.8% | |
Competitors are the stored peer set for WELL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.71B | 5.78B | 6.48B | 7.85B | 10.67B |
| Cost of Revenue | 2.77B | 3.56B | 3.95B | 4.83B | 6.49B |
| Gross Profit | 1.93B | 2.22B | 2.53B | 3.02B | 4.18B |
| Gross Margin | 41.1% | 38.4% | 39.1% | 38.5% | 39.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 126.73M | 150.39M | 179.09M | 235.49M | 1.75B |
| Operating Expenses | 1.17B | 1.47B | 1.59B | 1.88B | 3.82B |
| Depreciation & Amortization | 1.05B | 1.34B | 1.44B | 1.68B | 2.14B |
| EBITDA | 1.71B | 2.04B | 2.4B | 2.78B | 2.31B |
| EBITDA Margin | 36.4% | 35.3% | 37.1% | 35.4% | 21.7% |
| Operating Income | 763.36M | 746.22M | 940.45M | 1.15B | 355.17M |
| Operating Margin | 16.2% | 12.9% | 14.5% | 14.6% | 3.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 489.85M | 529.52M | 607.85M | 574.26M | 651.96M |
| Other Income / Expenses | (380.16M) | (578.41M) | (575.95M) | (170.14M) | 599.55M |
| Income Before Tax | 383.19M | 167.82M | 364.5M | 975.56M | 954.72M |
| Pre-Tax Margin | 8.1% | 2.9% | 5.6% | 12.4% | 9.0% |
| Income Tax Expense | 8.71M | 7.25M | 6.36M | 2.7M | (7.12M) |
| Net Income | 336.14M | 141.21M | 340.09M | 951.68M | 936.85M |
| Net Margin | 7.1% | 2.4% | 5.2% | 12.1% | 8.8% |
| EPS (Basic) | 0.79 | 0.31 | 0.66 | 1.58 | 1.41 |
| EPS (Diluted) | 0.78 | 0.30 | 0.66 | 1.57 | 1.39 |
| Weighted Avg Shares | 424.98M | 462.19M | 515.63M | 602.98M | 665.64M |
| Weighted Avg Shares (Diluted) | 426.84M | 465.16M | 518.7M | 608.75M | 679.52M |
Welltower Inc.
NYSE:WELL
Intrinsic Alpha fair value
Locked
Current Price
$247.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.